A vaccine targeting human IL-4 and IL-13 protects against asthma in humanized mice.

导出原文传递

翻译打印收藏纠错

第一作者： Emma,Lamanna

第一单位： Institut Pasteur, Université de Paris Cité, Inserm UMR 1222, Unit of Antibodies in Therapy and Pathology, Paris, France.;Neovacs SA, Suresnes, France.

作者： Emma,Lamanna ^[1] ; Eva,Conde ^[2] ; Aurélie,Mougel ^[3] ; Jonathan,Bonnefoy ^[4] ; Fabien,Colaone ^[4] ; Ophélie,Godon ^[5] ; Samir,Hamdi ^[4] ; Jasper B J,Kamphuis ^[6] ; Béatrice,Drouet ^[4] ; Vincent,Serra ^[4] ; Pierre,Bruhns ^[5] ; Laurent L,Reber ^[3]

作者单位： Institut Pasteur, Université de Paris Cité, Inserm UMR 1222, Unit of Antibodies in Therapy and Pathology, Paris, France.;Neovacs SA, Suresnes, France. ^[1] Institut Pasteur, Université de Paris Cité, Inserm UMR 1222, Unit of Antibodies in Therapy and Pathology, Paris, France.;Neovacs SA, Suresnes, France.;Sorbonne Université, College Doctoral, Paris, France. ^[2] Neovacs SA, Suresnes, France.;Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291, CNRS UMR5051, University Toulouse III, Toulouse, France. ^[3] Neovacs SA, Suresnes, France. ^[4] Institut Pasteur, Université de Paris Cité, Inserm UMR 1222, Unit of Antibodies in Therapy and Pathology, Paris, France. ^[5] Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291, CNRS UMR5051, University Toulouse III, Toulouse, France. ^[6]